US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist
  • 13.300
  • +0.590+4.64%
Trading Jul 12 10:31 ET
655.10MMarket Cap-2265P/E (TTM)

Regenxbio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.47%-55.46M
-5.26%-218.41M
-3.53%-40.76M
2.08%-49.41M
23.36%-47.32M
-44.73%-80.92M
-194.80%-207.49M
-111.53%-39.37M
-18.71%-50.46M
-71.18%-61.75M
Net income from continuing operations
5.02%-63.33M
6.00%-263.49M
-4.93%-62.89M
18.04%-61.87M
-5.69%-72.06M
13.10%-66.68M
-319.27%-280.32M
-120.38%-59.94M
-29.24%-75.48M
-18.29%-68.18M
Operating gains losses
----
-2,891.14%-2.21M
--0
----
----
----
101.52%79K
--0
100.14%7K
----
Depreciation and amortization
0.05%4.18M
34.17%17.32M
5.07%4.34M
23.19%4.37M
67.80%4.44M
61.25%4.18M
34.97%12.91M
58.33%4.13M
25.50%3.55M
20.08%2.64M
Other non cash items
188.65%617K
-125.82%-95K
170.37%475K
669.44%831K
-169.25%-705K
-738.55%-696K
-91.56%368K
-386.02%-675K
-82.61%108K
1,128.28%1.02M
Change In working capital
72.45%-8.16M
-177.89%-10.89M
35.61%9.22M
-106.24%-623K
214.33%10.13M
-589.94%-29.61M
-65.25%13.98M
-83.85%6.8M
599.44%9.99M
-212.24%-8.86M
-Change in receivables
-3.35%9.18M
-18.39%3.94M
-30.45%3.37M
-230.68%-6.54M
77.73%-2.39M
66.90%9.5M
-65.85%4.82M
-77.99%4.84M
178.19%5.01M
-245.49%-10.72M
-Change in prepaid assets
157.37%930K
-112.78%-620K
-312.01%-1.96M
79.52%2.55M
-82.19%409K
-871.90%-1.62M
158.83%4.85M
363.25%924K
126.77%1.42M
207.50%2.3M
-Change in payables and accrued expense
53.54%-8.62M
95.03%-339K
15.14%5.22M
7.26%5.05M
225.06%7.94M
-90.84%-18.55M
-124.73%-6.83M
-78.03%4.53M
-65.64%4.71M
-279.37%-6.35M
-Change in other current assets
66.74%-4.71M
-167.58%-3.2M
439.83%4.41M
-96.83%-124K
224.96%6.68M
-837.19%-14.15M
200.17%4.73M
203.16%816K
92.93%-63K
424.23%2.06M
-Change in other current liabilities
-10.38%-4.81M
-221.02%-9.16M
-365.03%-1.52M
-255.96%-1.55M
-550.65%-1.74M
-154.80%-4.35M
-38.80%7.57M
-121.52%-326K
-233.33%-436K
-93.90%385K
-Change in other working capital
68.82%-135K
-29.79%-1.51M
92.63%-294K
99.07%-6K
---779K
---433K
-29.59%-1.17M
---3.99M
---648K
----
Cash from discontinued investing activities
Operating cash flow
31.47%-55.46M
-5.26%-218.41M
-3.53%-40.76M
2.08%-49.41M
23.36%-47.32M
-44.73%-80.92M
-194.80%-207.49M
-111.53%-39.37M
-18.71%-50.46M
-71.18%-61.75M
Investing cash flow
Cash flow from continuing investing activities
-79.11%13.18M
1,700.66%190.94M
27.24%33.97M
-27.12%38.66M
5,208.05%55.22M
169.65%63.09M
97.07%-11.93M
112.34%26.7M
229.44%53.04M
-113.86%-1.08M
Net PPE purchase and sale
88.44%-557K
67.58%-9.96M
79.41%-1.13M
71.50%-1.44M
72.10%-2.58M
56.07%-4.82M
63.50%-30.72M
62.57%-5.47M
72.99%-5.05M
53.45%-9.24M
Net investment purchase and sale
-79.77%13.74M
968.92%200.9M
9.11%35.1M
-30.98%40.1M
608.62%57.8M
185.29%67.91M
105.83%18.8M
115.95%32.17M
66.94%58.09M
-70.49%8.16M
Cash from discontinued investing activities
Investing cash flow
-79.11%13.18M
1,700.66%190.94M
27.24%33.97M
-27.12%38.66M
5,208.05%55.22M
169.65%63.09M
97.07%-11.93M
112.34%26.7M
229.44%53.04M
-113.86%-1.08M
Financing cash flow
Cash flow from continuing financing activities
1,435.90%120.73M
-21.24%-34.97M
-34.10%-11.96M
11.30%-4.81M
-19.47%-9.16M
-32.24%-9.04M
-114.77%-28.84M
-17.12%-8.92M
-137.28%-5.42M
-24.96%-7.67M
Net common stock issuance
22,543.57%132.01M
284.62%6.7M
--0
446.16%6.12M
--0
-6.27%583K
-99.20%1.74M
--0
-1.84%1.12M
--0
Proceeds from stock option exercised by employees
87.69%884K
-45.76%1.52M
386.05%209K
-89.97%92K
-50.30%749K
39.76%471K
-34.50%2.8M
-95.63%43K
-46.96%917K
448.00%1.51M
Net other financing activities
-20.61%-12.17M
-29.36%-43.19M
-35.79%-12.17M
-47.76%-11.01M
-8.01%-9.91M
-29.49%-10.09M
-22.58%-33.39M
-4.21%-8.96M
-44.65%-7.45M
-43.11%-9.18M
Cash from discontinued financing activities
Financing cash flow
1,435.90%120.73M
-21.24%-34.97M
-34.10%-11.96M
11.30%-4.81M
-19.47%-9.16M
-32.24%-9.04M
-114.77%-28.84M
-17.12%-8.92M
-137.28%-5.42M
-24.96%-7.67M
Net cash flow
Beginning cash position
-63.07%36.55M
-71.49%98.98M
-54.14%55.3M
-42.58%70.86M
-62.81%72.12M
-71.49%98.98M
2.20%347.24M
-47.51%120.57M
-52.24%123.4M
-33.78%193.9M
Current changes in cash
392.07%78.45M
74.85%-62.43M
13.17%-18.75M
-449.65%-15.56M
98.20%-1.27M
82.48%-26.86M
-3,417.61%-248.26M
-118.37%-21.59M
90.13%-2.83M
-104.88%-70.5M
End cash Position
59.46%115.01M
-63.07%36.55M
-63.07%36.55M
-54.14%55.3M
-42.58%70.86M
-62.81%72.12M
-71.49%98.98M
-71.49%98.98M
-47.51%120.57M
-52.24%123.4M
Free cash flow
34.67%-56.01M
4.13%-228.37M
6.59%-41.89M
8.40%-50.85M
29.71%-49.9M
-28.20%-85.74M
-276.85%-238.21M
-113.72%-44.84M
9.31%-55.51M
-26.96%-70.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.47%-55.46M-5.26%-218.41M-3.53%-40.76M2.08%-49.41M23.36%-47.32M-44.73%-80.92M-194.80%-207.49M-111.53%-39.37M-18.71%-50.46M-71.18%-61.75M
Net income from continuing operations 5.02%-63.33M6.00%-263.49M-4.93%-62.89M18.04%-61.87M-5.69%-72.06M13.10%-66.68M-319.27%-280.32M-120.38%-59.94M-29.24%-75.48M-18.29%-68.18M
Operating gains losses -----2,891.14%-2.21M--0------------101.52%79K--0100.14%7K----
Depreciation and amortization 0.05%4.18M34.17%17.32M5.07%4.34M23.19%4.37M67.80%4.44M61.25%4.18M34.97%12.91M58.33%4.13M25.50%3.55M20.08%2.64M
Other non cash items 188.65%617K-125.82%-95K170.37%475K669.44%831K-169.25%-705K-738.55%-696K-91.56%368K-386.02%-675K-82.61%108K1,128.28%1.02M
Change In working capital 72.45%-8.16M-177.89%-10.89M35.61%9.22M-106.24%-623K214.33%10.13M-589.94%-29.61M-65.25%13.98M-83.85%6.8M599.44%9.99M-212.24%-8.86M
-Change in receivables -3.35%9.18M-18.39%3.94M-30.45%3.37M-230.68%-6.54M77.73%-2.39M66.90%9.5M-65.85%4.82M-77.99%4.84M178.19%5.01M-245.49%-10.72M
-Change in prepaid assets 157.37%930K-112.78%-620K-312.01%-1.96M79.52%2.55M-82.19%409K-871.90%-1.62M158.83%4.85M363.25%924K126.77%1.42M207.50%2.3M
-Change in payables and accrued expense 53.54%-8.62M95.03%-339K15.14%5.22M7.26%5.05M225.06%7.94M-90.84%-18.55M-124.73%-6.83M-78.03%4.53M-65.64%4.71M-279.37%-6.35M
-Change in other current assets 66.74%-4.71M-167.58%-3.2M439.83%4.41M-96.83%-124K224.96%6.68M-837.19%-14.15M200.17%4.73M203.16%816K92.93%-63K424.23%2.06M
-Change in other current liabilities -10.38%-4.81M-221.02%-9.16M-365.03%-1.52M-255.96%-1.55M-550.65%-1.74M-154.80%-4.35M-38.80%7.57M-121.52%-326K-233.33%-436K-93.90%385K
-Change in other working capital 68.82%-135K-29.79%-1.51M92.63%-294K99.07%-6K---779K---433K-29.59%-1.17M---3.99M---648K----
Cash from discontinued investing activities
Operating cash flow 31.47%-55.46M-5.26%-218.41M-3.53%-40.76M2.08%-49.41M23.36%-47.32M-44.73%-80.92M-194.80%-207.49M-111.53%-39.37M-18.71%-50.46M-71.18%-61.75M
Investing cash flow
Cash flow from continuing investing activities -79.11%13.18M1,700.66%190.94M27.24%33.97M-27.12%38.66M5,208.05%55.22M169.65%63.09M97.07%-11.93M112.34%26.7M229.44%53.04M-113.86%-1.08M
Net PPE purchase and sale 88.44%-557K67.58%-9.96M79.41%-1.13M71.50%-1.44M72.10%-2.58M56.07%-4.82M63.50%-30.72M62.57%-5.47M72.99%-5.05M53.45%-9.24M
Net investment purchase and sale -79.77%13.74M968.92%200.9M9.11%35.1M-30.98%40.1M608.62%57.8M185.29%67.91M105.83%18.8M115.95%32.17M66.94%58.09M-70.49%8.16M
Cash from discontinued investing activities
Investing cash flow -79.11%13.18M1,700.66%190.94M27.24%33.97M-27.12%38.66M5,208.05%55.22M169.65%63.09M97.07%-11.93M112.34%26.7M229.44%53.04M-113.86%-1.08M
Financing cash flow
Cash flow from continuing financing activities 1,435.90%120.73M-21.24%-34.97M-34.10%-11.96M11.30%-4.81M-19.47%-9.16M-32.24%-9.04M-114.77%-28.84M-17.12%-8.92M-137.28%-5.42M-24.96%-7.67M
Net common stock issuance 22,543.57%132.01M284.62%6.7M--0446.16%6.12M--0-6.27%583K-99.20%1.74M--0-1.84%1.12M--0
Proceeds from stock option exercised by employees 87.69%884K-45.76%1.52M386.05%209K-89.97%92K-50.30%749K39.76%471K-34.50%2.8M-95.63%43K-46.96%917K448.00%1.51M
Net other financing activities -20.61%-12.17M-29.36%-43.19M-35.79%-12.17M-47.76%-11.01M-8.01%-9.91M-29.49%-10.09M-22.58%-33.39M-4.21%-8.96M-44.65%-7.45M-43.11%-9.18M
Cash from discontinued financing activities
Financing cash flow 1,435.90%120.73M-21.24%-34.97M-34.10%-11.96M11.30%-4.81M-19.47%-9.16M-32.24%-9.04M-114.77%-28.84M-17.12%-8.92M-137.28%-5.42M-24.96%-7.67M
Net cash flow
Beginning cash position -63.07%36.55M-71.49%98.98M-54.14%55.3M-42.58%70.86M-62.81%72.12M-71.49%98.98M2.20%347.24M-47.51%120.57M-52.24%123.4M-33.78%193.9M
Current changes in cash 392.07%78.45M74.85%-62.43M13.17%-18.75M-449.65%-15.56M98.20%-1.27M82.48%-26.86M-3,417.61%-248.26M-118.37%-21.59M90.13%-2.83M-104.88%-70.5M
End cash Position 59.46%115.01M-63.07%36.55M-63.07%36.55M-54.14%55.3M-42.58%70.86M-62.81%72.12M-71.49%98.98M-71.49%98.98M-47.51%120.57M-52.24%123.4M
Free cash flow 34.67%-56.01M4.13%-228.37M6.59%-41.89M8.40%-50.85M29.71%-49.9M-28.20%-85.74M-276.85%-238.21M-113.72%-44.84M9.31%-55.51M-26.96%-70.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg